T Cell Transfer Therapy Market: Explosive Growth Driven by CAR-T and TCR Therapies, Personalized Immuno-Oncology, and Expanding Clinical Indications
The T Cell Transfer Therapy Market is experiencing explosive growth as CAR-T and TCR-based therapies gain traction, personalized immuno-oncology advances, and clinical indications expand across hematologic cancers and solid tumors. The global T cell transfer therapy market was valued at about USD 6.12 billion in 2024 and is projected to reach approximately USD 31.5 billion by 2032, growing at a...
0 Commentarii 0 Distribuiri 79 Views 0 previzualizare